# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY AND INSTRUMENT COMBINATION TEMPLATE

A. 510(k) Number: k070704 B. Purpose for Submission: New submission for the TRILOGY Analyzer for the determination Glucose, Creatinine, Urea nitrogen, Chloride, Potassium, and Sodium using previously cleared reagents and ISE test systems from the following submissions: JAS Diagnostics, Inc. Glucose Hexokinase (Liquid) Reagent (k011900) JAS Diagnostics, Inc. Creatinine (Single Vial) Reagent (k003247) JAS Diagnostics, Inc. Urea Nitrogen (BUN) Liquid Reagent (k011596) Medica Corp. EasyElectrolytes Analyzer (k000926) C. Measurand: Glucose, Creatinine, Urea nitrogen, Chloride, Potassium, and Sodium D. Type of Test: Quantitative photometric and Ion Selective Electrode methods. E. Applicant: Drew Scientific, Inc. F. Proprietary and Established Names: TRILOGY Analyzer G. Regulatory Information:   
1. Regulation section:   
21CFR - Sec 862.1345 - Glucose test system.   
21CFR - Sec 862.1225 - Creatinine test system.   
21CFR - Sec 862.1770 - Urea nitrogen test system.   
21CFR - Sec 862.1170 - Chloride test system.   
21CFR - Sec 862.1600 - Potassium test system.   
21CFR - Sec 862.1665 - Sodium test system.   
21CFR - Sec 862.2160 - Discrete Photometric Chemistry Analyzer for Clinical Use

2. Classification: Class II for all except for Sec 862.2160 which is Class I

3. Product code: CGA - Glucose Oxidase, Glucose CGX - Alkaline Picrate, Colorimetry, Creatinine CDQ - Urease And Glutamic Dehydrogenase, Urea Nitrogen CGZ - Electrode, Ion-Specific, Chloride CEM - Electrode, Ion Specific, Potassium JGS - Electrode, Ion Specific, Sodium JJE - Analyzer, Chemistry (Photometric, Discrete), For Clinical Use

4. Panel: Chemistry (75)

# H. Intended Use:

1. Intended use(s): See indications for use below

2. Indication(s) for use:

TRILOGY is a fully automated, discrete, software-driven, multi-purpose analyzer for spectrophotometric and potentiometric in vitro determination of analytes in body fluids. It is an open system intended for clinical use in a professional setting for use with various chemistry assays that may be adaptable to the analyzer depending on the reagent used to induce a photometric reaction.

TRILOGY is intended for the quantitative determination of glucose, creatinine and urea nitrogen in serum. Glucose measurements are used in the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus, neonatal hypoglycemia and idiopathic hypoglycemia, and of pancreatic islet cell carcinoma. Creatinine measurements are used in the diagnosis and treatment of renal diseases, and in monitoring renal dialysis. Urea nitrogen measurements are used in the diagnosis and treatment of certain renal and metabolic diseases.

TRILOGY includes an optional Ion Selective Electrodes (ISE) module for the measurement of sodium, potassium, and chloride in serum and urine. These measurements are used to monitor electrolyte balance and in the diagnosis and treatment of diseases involving electrolyte imbalance.

3. Special conditions for use statement(s): Prescription use   
4. Special instrument requirements: TRILOGY Analyzer

# I. Device Description:

The TRILOGY Analyzer is composed of a carousel system for reagent bottles/tubes and sample tubes, a carousel compartment with refrigeration unit, barcode reader, a liquid distribution module, microplate platform, wash station and an optical module. Reagent bottles/tubes and sample tubes are loaded onto a specific reagent or sample carousel and are placed into the refrigeration unit of the TRILOGY Analyzer. Located within the refrigeration unit is a barcode scanner, which scans barcodelabeled reagents and specimens for identification. Reagents and specimens are acquired from the carousels via the liquid distribution module. The liquid distribution module is composed of two probes, the Sample (Small) probe and the Reagent (Large) probe. The Sample (Small) probe is used to aspirate and dispense volumes between 1 and $7 5 \mu \mathrm { L }$ . It is primarily used for samples but can also be used for delivering small volumes of reagent. The Reagent (Large) probe is used to aspirate and dispense volumes between 40 and $2 5 0 ~ \mu \mathrm { L }$ and is primarily used for reagents. Reagents and samples are pipetted by the Reagent or Sample probes into the 96-well microplate located on the analyzer deck. In between each aspiration, both probes are rinsed internally and externally at the washing station to insure proper decontamination. Once the reagents and samples have been added to the 96-well plate, the optical module scans the plate and conducts light through each reaction well. The light received from each reaction well is measured by the spectrophotometer and the data sent to the computer for analysis.

Serum or urine samples are pipetted from the sample carousel into the ISE module through the ion selective electrode injection well. The specimen is then introduced into the ISE module and pumped through each ion selective electrode. When the sample passes each individual electrode, the electrical potential of the individual electrode is measured and the data are sent to the computer for analysis.

See k011900, k003247, k011596, and k000926 for descriptive details for the reagents.

# J. Substantial Equivalence Information:

1. Predicate device name(s):

Roche Diagnostic Systems, Inc. Roche COBAS MIRA Chemistry System • JAS Diagnostics, Inc. Glucose Hexokinase (Liquid) Reagent • JAS Diagnostics, Inc. Creatinine (Single Vial) Reagent JAS Diagnostics, Inc. Urea Nitrogen (BUN) Liquid Reagent Medica Corp. EasyElectrolytes Analyzer

2. Predicate 510(k) number(s): k851172, k011900, k003247, k011596, and k000926

3. Comparison with predicate:

# Comparison of TRILOGY Analyzer and Predicate Device – Roche COBAS MIRA®

<table><tr><td rowspan=1 colspan=1>Characteristics</td><td rowspan=1 colspan=1>Drew Scientific, Inc.TRILOGY Analyzer</td><td rowspan=1 colspan=1>Roche Diagnostics, Inc.Roche COBAS MIRA</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>TRILOGY is a fully automated,discrete, software-driven, multi-purpose analyzer forspectrophotometric andpotentiometric in vitrodetermination of analytes inbody fluids. It is intended forclinical use in a professionalsetting for a variety of generalchemistries. It includes anoptional Ion Selective Electrodes(ISE) module for themeasurement of sodium,potassium and chloride.</td><td rowspan=1 colspan=1>The COBAS MIRA® is a benchtoprandom access analyzer used foranalysis in clinical chemistry withoptional ion selective electrodemodule.</td></tr><tr><td rowspan=1 colspan=1>System Principle</td><td rowspan=1 colspan=1>Clinical chemistry analysesincludingend point, kinetic andfixed time assays in either aRoutine or STAT mode</td><td rowspan=1 colspan=1>Selective analysis of chemistries ineither a Routine or STAT mode</td></tr></table>

Comparison of TRILOGY Analyzer and Predicate Device – Medica Corp. EasyElectrolytes   

<table><tr><td rowspan=1 colspan=1>Characteristics</td><td rowspan=1 colspan=1>Drew Scientific, Inc.TRILOGY Analyzer</td><td rowspan=1 colspan=1>Roche Diagnostics, Inc.Roche COBAS MIRA®</td></tr><tr><td rowspan=1 colspan=1>Open/Closed Reagent System</td><td rowspan=1 colspan=1>Open</td><td rowspan=1 colspan=1>Open</td></tr><tr><td rowspan=1 colspan=1>Principles of Measurement</td><td rowspan=1 colspan=1>Spectrophotometric  parallelbi-chromatic measurement oflight absorbance (Tungstenhalogen lamp)Potentiometric  Direct (Serum)Indirect (Urine)</td><td rowspan=1 colspan=1>Monochromatic measurement oflight absorbancePotentiometric  Direct (Serum)Indirect (Urine)</td></tr><tr><td rowspan=1 colspan=1>Light Source</td><td rowspan=1 colspan=1>Tungsten Halogen</td><td rowspan=1 colspan=1>Xenon Flash Tube</td></tr><tr><td rowspan=1 colspan=1>Reaction Vessel</td><td rowspan=1 colspan=1>96-well Microplate</td><td rowspan=1 colspan=1>Six 12-Cuvette Segments</td></tr><tr><td rowspan=1 colspan=1>ThroughputWithout ISEWith ISE</td><td rowspan=1 colspan=1>170 tests/hour280 tests/hour</td><td rowspan=1 colspan=1>140 tests/hour</td></tr><tr><td rowspan=1 colspan=1>Specimen Type(Chemistry Methods)</td><td rowspan=1 colspan=1>Serum</td><td rowspan=1 colspan=1>Serum and Plasma</td></tr><tr><td rowspan=1 colspan=1>Specimen Capacity</td><td rowspan=1 colspan=1>40 Tubes</td><td rowspan=1 colspan=1>150 Tubes</td></tr><tr><td rowspan=1 colspan=1>Barcode Reader</td><td rowspan=1 colspan=1>Integrated</td><td rowspan=1 colspan=1>None</td></tr><tr><td rowspan=1 colspan=1>Barcode Formats</td><td rowspan=1 colspan=1>Code 39, Code 128, Code 93,Interleaved 2 of 5, Code 2 of 5,EAN, UPC A</td><td rowspan=1 colspan=1>Not applicable</td></tr><tr><td rowspan=1 colspan=1>Probe Movement</td><td rowspan=1 colspan=1>XYZ</td><td rowspan=1 colspan=1>XYZ</td></tr><tr><td rowspan=1 colspan=1>Primary Tubes</td><td rowspan=1 colspan=1>1.5, 5, 7 and 10 mL</td><td rowspan=1 colspan=1>Sample Cup, 4, 10, 15 and 35 mL</td></tr><tr><td rowspan=1 colspan=1>Specimen Volume</td><td rowspan=1 colspan=1>1 to 75 μL</td><td rowspan=1 colspan=1>2 to 95 μL</td></tr><tr><td rowspan=1 colspan=1>Dilution of Specimens</td><td rowspan=1 colspan=1>Yes</td><td rowspan=1 colspan=1>Yes</td></tr><tr><td rowspan=1 colspan=1>Cross ContaminationPrevention</td><td rowspan=1 colspan=1>Teflon® - coated,Washable Probes</td><td rowspan=1 colspan=1>Washable Probe</td></tr><tr><td rowspan=1 colspan=1>Reagent Type</td><td rowspan=1 colspan=1>Liquid</td><td rowspan=1 colspan=1>Liquid</td></tr><tr><td rowspan=1 colspan=1>Reagent Volume</td><td rowspan=1 colspan=1>1 to 250 μL</td><td rowspan=1 colspan=1>100 to 600 μL</td></tr><tr><td rowspan=1 colspan=1>Reagent PositionsOnboard</td><td rowspan=1 colspan=1>Maximum 40 Tubes (10 mL)Varies with Carousel Set</td><td rowspan=1 colspan=1>Varies with Reagent Rack Set</td></tr><tr><td rowspan=1 colspan=1>Reaction Volume</td><td rowspan=1 colspan=1>80 to 450 μL</td><td rowspan=1 colspan=1>150 to 600 μL</td></tr><tr><td rowspan=1 colspan=1>Host Interface</td><td rowspan=1 colspan=1>Bidirectional RS-232C</td><td rowspan=1 colspan=1>Bidirectional RS-232C</td></tr><tr><td rowspan=1 colspan=1>Calibration Curve</td><td rowspan=1 colspan=1>Linear and Non-linear</td><td rowspan=1 colspan=1>Linear and Non-linear</td></tr><tr><td rowspan=1 colspan=1>User Setting</td><td rowspan=1 colspan=1>Clinical Laboratory</td><td rowspan=1 colspan=1>Clinical Laboratory</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Characteristics</td><td rowspan=1 colspan=1>Drew Scientific, Inc.TRILOGY Analyzer</td><td rowspan=1 colspan=1>Medica Corp.EasyElectrolytes</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>TRILOGY is a fully automated,discrete, software-driven, multi-purpose analyzer forspectrophotometric andpotentiometric in vitrodetermination of analytes inbody fluids. It is intended forclinical use in a professionalsetting for a variety of generalchemistries. It includes anoptional Ion Selective Electrodes(ISE) module for the</td><td rowspan=1 colspan=1>The EasyElectolytes Analyzer isdesigned for clinical laboratoryuse, for quantitativemeasurements of sodium,potassium, and chloride orlithium.</td></tr></table>

Comparison of TRILOGY Analyzer with Predicate Device – JAS Diagnostics, Inc. Glucose Hexokinase (Liquid) Reagent   

<table><tr><td rowspan=1 colspan=1>Characteristics</td><td rowspan=1 colspan=1>Drew Scientific, Inc.TRILOGY Analyzer</td><td rowspan=1 colspan=1>Medica Corp.EasyElectrolytes</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>measurement of sodium,potassium and chloride.</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>System Principle</td><td rowspan=1 colspan=1>Measurement of electrolytes in abiological matrix</td><td rowspan=1 colspan=1>Measurement of electrolytes in abiological matrix</td></tr><tr><td rowspan=1 colspan=1>Specimen Type</td><td rowspan=1 colspan=1>Serum and Urine</td><td rowspan=1 colspan=1>Serum, Plasma, Whole Bloodand Urine</td></tr><tr><td rowspan=1 colspan=1>Principles of Measurement</td><td rowspan=1 colspan=1>Potentiometric - Direct (Serum)Indirect (Urine)</td><td rowspan=1 colspan=1>Potentiometric  Direct (Serum)Indirect (Urine)</td></tr><tr><td rowspan=1 colspan=1>Specimen Volume</td><td rowspan=1 colspan=1>65 μL (Serum)165 μL (Diluted Urine)</td><td rowspan=1 colspan=1>55 μL (Specimen Container)50 μL (Capillary)300 μL (Diluted Urine)</td></tr><tr><td rowspan=1 colspan=1>Primary Tubes</td><td rowspan=1 colspan=1>1.5, 5, 7 and 10 mL</td><td rowspan=1 colspan=1>Vacuum collection tube,syringe sample or capillary</td></tr><tr><td rowspan=1 colspan=1>Cross Contamination Prevention</td><td rowspan=1 colspan=1>Washable Probe</td><td rowspan=1 colspan=1>Washable Probe</td></tr><tr><td rowspan=1 colspan=1>ThroughputSerumUrine</td><td rowspan=1 colspan=1>180 tests/hour111 tests/hour</td><td rowspan=1 colspan=1>70 tests/hour60 tests/hour</td></tr><tr><td rowspan=1 colspan=1>Host Interface</td><td rowspan=1 colspan=1>Bidirectional RS-232C</td><td rowspan=1 colspan=1>Bidirectional RS-232C</td></tr><tr><td rowspan=1 colspan=1>User Setting</td><td rowspan=1 colspan=1>Clinical Laboratory</td><td rowspan=1 colspan=1>Clinical Laboratory</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Characteristics</td><td rowspan=1 colspan=1>Drew Scientific, Inc.TRILOGY Analyzer withJAS Diagnostics, Inc.Glucose Hexokinase(Liquid) Reagent</td><td rowspan=1 colspan=1>JAS Diagnostics, Inc.Glucose Hexokinase(Liquid) Reagent</td></tr><tr><td rowspan=1 colspan=1>Instrument</td><td rowspan=1 colspan=1>TRILOGY Analyzer</td><td rowspan=1 colspan=1>Various Instruments</td></tr><tr><td rowspan=1 colspan=1>Method</td><td rowspan=1 colspan=1>Enzymatic method usinghexokinase coupled withglucose-6-phosphatedehydrogenase</td><td rowspan=1 colspan=1>Enzymatic method usinghexokinase coupled withglucose-6-phosphatedehydrogenase</td></tr><tr><td rowspan=1 colspan=1>Specimen</td><td rowspan=1 colspan=1>Serum</td><td rowspan=1 colspan=1>Serum</td></tr><tr><td rowspan=1 colspan=1>Component ReagentPackaging</td><td rowspan=1 colspan=1>Single, reagent bottle,ready to use</td><td rowspan=1 colspan=1>Single, reagent bottle,ready to use</td></tr><tr><td rowspan=1 colspan=1>Format</td><td rowspan=1 colspan=1>Liquid</td><td rowspan=1 colspan=1>Liquid</td></tr><tr><td rowspan=1 colspan=1>Reagent</td><td rowspan=1 colspan=1>ATP, NAD, hexokinase,glucose-6-phosphate-dehydrogenase, sodium azide,stabilizers and fillers</td><td rowspan=1 colspan=1>ATP, NAD, hexokinase,glucose-6-phosphate-dehydrogenase, sodiumazide, stabilizers andfillers</td></tr></table>

Comparison of TRILOGY Analyzer and Predicate Device – JAS Diagnostics, Inc. Creatinine (Single Vial) Reagent   

<table><tr><td rowspan=1 colspan=1>Characteristics</td><td rowspan=1 colspan=1>Drew Scientific, Inc.TRILOGY Analyzer withJAS Diagnostics, Inc.Creatinine (Single Vial)Reagent</td><td rowspan=1 colspan=1>JAS Diagnostics, Inc.Creatinine (Single Vial)Reagent</td></tr><tr><td rowspan=1 colspan=1>Instrument</td><td rowspan=1 colspan=1>TRILOGY Analyzer</td><td rowspan=1 colspan=1>Various Instruments</td></tr><tr><td rowspan=1 colspan=1>Method</td><td rowspan=1 colspan=1>Kinetic modification of the Jaffemethod using picric acid andsodium hydroxide</td><td rowspan=1 colspan=1>Kinetic modification ofthe Jaffe method usingpicric acid and sodiumhydroxide</td></tr><tr><td rowspan=1 colspan=1>Specimen</td><td rowspan=1 colspan=1>Serum</td><td rowspan=1 colspan=1>Serum</td></tr><tr><td rowspan=1 colspan=1>Component ReagentPackaging</td><td rowspan=1 colspan=1>Single, reagent bottle,ready to use</td><td rowspan=1 colspan=1>Single, reagent bottle,ready to use</td></tr><tr><td rowspan=1 colspan=1>Format</td><td rowspan=1 colspan=1>Liquid</td><td rowspan=1 colspan=1>Liquid</td></tr><tr><td rowspan=1 colspan=1>Reagent</td><td rowspan=1 colspan=1>Picric acid,sodium hydroxide</td><td rowspan=1 colspan=1>Picric acid,sodium hydroxide</td></tr></table>

Comparison of TRILOGY Analyzer and Predicate Device – JAS Diagnostics, Inc. Urea Nitrogen (BUN) Liquid Reagent   

<table><tr><td rowspan=1 colspan=1>Characteristics</td><td rowspan=1 colspan=1>Drew Scientific, Inc.TRILOGY Analyzer withJAS Diagnostics, Inc.Urea Nitrogen (BUN)Liquid Reagent</td><td rowspan=1 colspan=1>JAS Diagnostics, Inc.Urea Nitrogen (BUN)Liquid Reagent</td></tr><tr><td rowspan=1 colspan=1>Instrument</td><td rowspan=1 colspan=1>TRILOGY Analyzer</td><td rowspan=1 colspan=1>Various Instruments</td></tr><tr><td rowspan=1 colspan=1>Method</td><td rowspan=1 colspan=1>Enzymatic methodusing urease</td><td rowspan=1 colspan=1>Enzymatic methodusing urease</td></tr><tr><td rowspan=1 colspan=1>Specimen</td><td rowspan=1 colspan=1>Serum</td><td rowspan=1 colspan=1>Serum</td></tr><tr><td rowspan=1 colspan=1>Component ReagentPackaging</td><td rowspan=1 colspan=1>Single, reagent bottle,ready to use</td><td rowspan=1 colspan=1>Single, reagent bottle,ready to use</td></tr><tr><td rowspan=1 colspan=1>Format</td><td rowspan=1 colspan=1>Liquid</td><td rowspan=1 colspan=1>Liquid</td></tr><tr><td rowspan=1 colspan=1>Reagent</td><td rowspan=1 colspan=1>α-Ketogluterate, NADH,urease,GLDH, stabilizersand fillers</td><td rowspan=1 colspan=1>α-Ketogluterate, NADH,urease,GLDH, stabilizersand fillers</td></tr></table>

# K. Standard/Guidance Document Referenced (if applicable):

CLSI - Evaluation of Precision Performance of Clinical Chemistry Devices - EP05-A2 CLSI - Method Comparison and Bias Estimation Using Patient Samples - EP09-A2 CLSI - Evaluation of the Linearity of Quantitative Analytical Methods - EP06-A CLSI - Protocols for Determination of Limits of Detection and Limits of Quantitation - EP17-A Guidance for Industry In Vitro Diagnostic Chloride Test System; Final - 7/6/1998 Guidance for Industry In Vitro Diagnostic Creatinine Test System; Final - 7/2/1998 Guidance for Industry In Vitro Diagnostic Glucose Test System; Final - 7/6/1998

Guidance for Industry In Vitro Diagnostic Potassium Test System; Final - 7/6/1998 Guidance for Industry In Vitro Diagnostic Sodium Test System; Final - 7/6/1998 Guidance for Industry In Vitro Diagnostic Urea Nitrogen Test System; Final - 7/6/1998   
• Guidance for Off-the-Shelf Software Use in Medical Devices; Final - 9/9/1999   
• Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices - 5/11/2005   
• IEC 61010-1:2001, Safety requirements for electrical equipment for measurement, control and laboratory use. Part 1: General requirements IEC 61326 (02), Electrical equipment for measurement, control and laboratory use – EMC requirements E $\vee ~ 6 1 3 2 6 ~ ( 9 7 ) + \mathrm { A } 1 ~ ( 9 8 ) + \mathrm { A } 2 ~ ( 0 1 ) + \mathrm { A } 3$ (03), Electrical equipment for measurement, control and laboratory use – EMC requirements FCC Part 15 (06), Telecommunication, Chapter 1: Federal communications commission, Pa 15: Radio frequency devices ISO 14971 Medical devices -- Application of risk management to medical devices

# L. Test Principle:

Photometric methods and ISE see k011900, k003247, k011596, and k000926 for reagent principle details.

# M. Performance Characteristics (if/when applicable):

1. Analytical performance: a. Precision/Reproducibility:

Precision studies were performed following the CLSI standard, EP5A-2: Evaluation of Precision Performance of Quantitative Measurement Methods; Approved Guideline,

Within-run precision studies consisted of assaying each control in replicates of 20 for one (1) run. Total precision studies for the clinical chemistry methods consisted of assaying each control in replicates of two (2), twice a day for a total of 20 days.

<table><tr><td colspan="10" rowspan="1">Precision - Clinical Chemistry</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="3" rowspan="1">GlucoseHexokinase</td><td colspan="3" rowspan="1">Creatinine</td><td colspan="3" rowspan="1">Urea Nitrogen(BUN)</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Level1</td><td colspan="1" rowspan="1">Level2</td><td colspan="1" rowspan="1">Level3</td><td colspan="1" rowspan="1">Level1</td><td colspan="1" rowspan="1">Level2</td><td colspan="1" rowspan="1">Level3</td><td colspan="1" rowspan="1">Level1</td><td colspan="1" rowspan="1">Level2</td><td colspan="1" rowspan="1">Level3</td></tr><tr><td colspan="1" rowspan="1">Mean(mg/dL)</td><td colspan="1" rowspan="1">72.3</td><td colspan="1" rowspan="1">102.7</td><td colspan="1" rowspan="1">291.2</td><td colspan="1" rowspan="1">1.26</td><td colspan="1" rowspan="1">7.17</td><td colspan="1" rowspan="1">11.57</td><td colspan="1" rowspan="1">8.42</td><td colspan="1" rowspan="1">12.25</td><td colspan="1" rowspan="1">50.49</td></tr><tr><td colspan="1" rowspan="1">Within-RunSD%CV</td><td colspan="1" rowspan="1">1.902.6</td><td colspan="1" rowspan="1">1.601.5</td><td colspan="1" rowspan="1">2.700.9</td><td colspan="1" rowspan="1">0.043.2</td><td colspan="1" rowspan="1">0.141.9</td><td colspan="1" rowspan="1">0.272.3</td><td colspan="1" rowspan="1">0.414.9</td><td colspan="1" rowspan="1">0.423.4</td><td colspan="1" rowspan="1">0.861.7</td></tr><tr><td colspan="1" rowspan="1">TotalSD%CV</td><td colspan="1" rowspan="1">3.104.3</td><td colspan="1" rowspan="1">2.902.8</td><td colspan="1" rowspan="1">5.101.7</td><td colspan="1" rowspan="1">0.054.3</td><td colspan="1" rowspan="1">0.212.9</td><td colspan="1" rowspan="1">0.443.8</td><td colspan="1" rowspan="1">0.546.5</td><td colspan="1" rowspan="1">0.494.0</td><td colspan="1" rowspan="1">1.272.5</td></tr><tr><td colspan="10" rowspan="1">Precision - ISE Serum</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="3" rowspan="1">SODIUM</td><td colspan="3" rowspan="1">POTASSIUM</td><td colspan="3" rowspan="1">CHLORIDE</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Level1</td><td colspan="1" rowspan="1">Level2</td><td colspan="1" rowspan="1">Level3</td><td colspan="1" rowspan="1">Level1</td><td colspan="1" rowspan="1">Level2</td><td colspan="1" rowspan="1">Level3</td><td colspan="1" rowspan="1">Level1</td><td colspan="1" rowspan="1">Level2</td><td colspan="1" rowspan="1">Level3</td></tr><tr><td colspan="1" rowspan="1">Mean(mmol/L)</td><td colspan="1" rowspan="1">118.4</td><td colspan="1" rowspan="1">142.7</td><td colspan="1" rowspan="1">160.53</td><td colspan="1" rowspan="1">2.22</td><td colspan="1" rowspan="1">3.98</td><td colspan="1" rowspan="1">7.77</td><td colspan="1" rowspan="1">79.00</td><td colspan="1" rowspan="1">100.21</td><td colspan="1" rowspan="1">117.96</td></tr><tr><td colspan="1" rowspan="1">Within-RunSD%CV</td><td colspan="1" rowspan="1">0.700.6</td><td colspan="1" rowspan="1">0.700.5</td><td colspan="1" rowspan="1">0.780.5</td><td colspan="1" rowspan="1">0.020.7</td><td colspan="1" rowspan="1">0.010.2</td><td colspan="1" rowspan="1">0.020.3</td><td colspan="1" rowspan="1">0.370.5</td><td colspan="1" rowspan="1">0.260.3</td><td colspan="1" rowspan="1">0.260.2</td></tr><tr><td colspan="1" rowspan="1">TotalSD%CV</td><td colspan="1" rowspan="1">1.201.0</td><td colspan="1" rowspan="1">1.401.0</td><td colspan="1" rowspan="1">1.681.0</td><td colspan="1" rowspan="1">0.052.1</td><td colspan="1" rowspan="1">0.041.1</td><td colspan="1" rowspan="1">0.101.3</td><td colspan="1" rowspan="1">1.421.8</td><td colspan="1" rowspan="1">0.700.7</td><td colspan="1" rowspan="1">0.820.7</td></tr></table>

Only within run precision studies were performed for the ISE urine methods:

<table><tr><td rowspan=1 colspan=7>Precision - ISE Urine</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=2>Sodium</td><td rowspan=1 colspan=2>Potassium</td><td rowspan=1 colspan=2>Chloride</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Level1</td><td rowspan=1 colspan=1>Level2</td><td rowspan=1 colspan=1>Level1</td><td rowspan=1 colspan=1>Level2</td><td rowspan=1 colspan=1>Level1</td><td rowspan=1 colspan=1>Level2</td></tr><tr><td rowspan=1 colspan=1>Mean (mmol/L)</td><td rowspan=1 colspan=1>92.0</td><td rowspan=1 colspan=1>159.0</td><td rowspan=1 colspan=1>36.59</td><td rowspan=1 colspan=1>63.30</td><td rowspan=1 colspan=1>96.25</td><td rowspan=1 colspan=1>142.94</td></tr><tr><td rowspan=1 colspan=1>Within-RunSD%CV</td><td rowspan=1 colspan=1>1.301.5</td><td rowspan=1 colspan=1>2.001.2</td><td rowspan=1 colspan=1>0.381.0</td><td rowspan=1 colspan=1>0.671.1</td><td rowspan=1 colspan=1>0.670.7</td><td rowspan=1 colspan=1>1.310.9</td></tr></table>

$b$ . Linearity/assay reportable range:

The range of measurement (dynamic range) for the photometric assays are supported by Linearity and Detection limit studies:

Glucose – 12 to $5 0 0 \mathrm { m g / d l }$ Creatinine – 0.2 to $2 0 \mathrm { m g / d l }$ Urea Nitrogen – 4.7 to $1 1 5 . 0 \mathrm { m g / d l }$

Samples for the linearity studies were prepared following the CLSI standard, EP6-A: Evaluation of the Linearity of Quantitative Measurement Procedures: A Statistical Approach; Approved Guideline. The procedure used to evaluate linearity was to assay a series of samples with known analyte concentrations using commercially available reference standard materials.

<table><tr><td rowspan=1 colspan=4>Linearity  Clinical Chemistry</td></tr><tr><td rowspan=1 colspan=1>Key Statistics</td><td rowspan=1 colspan=1>GlucoseHexokinase</td><td rowspan=1 colspan=1>Creatinine</td><td rowspan=1 colspan=1>Urea Nitrogen(BUN)</td></tr><tr><td rowspan=1 colspan=1>Linearity Panel Members (N)</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>9</td></tr><tr><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>0.9986</td><td rowspan=1 colspan=1>1.004</td><td rowspan=1 colspan=1>0.9911</td></tr><tr><td rowspan=1 colspan=1>Intercept (mg/dL)</td><td rowspan=1 colspan=1>2.2</td><td rowspan=1 colspan=1>0.38</td><td rowspan=1 colspan=1>-2.20</td></tr><tr><td rowspan=1 colspan=1>Maximum Deviation from 100%</td><td rowspan=1 colspan=1>2.7% at 210 mg/dL</td><td rowspan=1 colspan=1>13.4% at 2.4 mg/dL</td><td rowspan=1 colspan=1>14.8% at 14.5 mg/dL</td></tr><tr><td rowspan=1 colspan=1>Maximum Deviation fromLinearity</td><td rowspan=1 colspan=1>4.7 mg/dL (1.8%) at260 mg/dL</td><td rowspan=1 colspan=1>-0.49 mg/dL (-2.0%)at 23.8 mg/dL</td><td rowspan=1 colspan=1>3.32 mg/dL (2.6%) at126.5 mg/dL</td></tr><tr><td rowspan=1 colspan=1>Range (mg/dL)</td><td rowspan=1 colspan=1>11.0 - 508.0</td><td rowspan=1 colspan=1>0.05- 23.80</td><td rowspan=1 colspan=1>0.50- 126.50</td></tr></table>

<table><tr><td rowspan=1 colspan=4>Linearity - ISE Serum</td></tr><tr><td rowspan=1 colspan=1>Key Statistics</td><td rowspan=1 colspan=1>Sodium</td><td rowspan=1 colspan=1>Potassium</td><td rowspan=1 colspan=1>Chloride</td></tr><tr><td rowspan=1 colspan=1>Linearity Panel Members (N)</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>10</td></tr><tr><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>0.989</td><td rowspan=1 colspan=1>0.994</td><td rowspan=1 colspan=1>0.918</td></tr><tr><td rowspan=1 colspan=1>Intercept (mmol/L)</td><td rowspan=1 colspan=1>3.60</td><td rowspan=1 colspan=1>-0.04</td><td rowspan=1 colspan=1>14.69</td></tr><tr><td rowspan=1 colspan=1>Systematic Error (mmol/L):ObservedAllowed</td><td rowspan=1 colspan=1>1.321.40</td><td rowspan=1 colspan=1>0.110.14</td><td rowspan=1 colspan=1>1.5%1.8%</td></tr><tr><td rowspan=1 colspan=1>Range (mmol/L)</td><td rowspan=1 colspan=1>104.30 - 209.00</td><td rowspan=1 colspan=1>0.94 - 11.79</td><td rowspan=1 colspan=1>52.47 - 172.07</td></tr></table>

<table><tr><td rowspan=1 colspan=4>Linearity - ISE Urine</td></tr><tr><td rowspan=1 colspan=1>Key Statistics</td><td rowspan=1 colspan=1>Sodium</td><td rowspan=1 colspan=1>Potassium</td><td rowspan=1 colspan=1>Chloride</td></tr><tr><td rowspan=1 colspan=1>Linearity Panel Members (N)</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>8</td></tr><tr><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>0.969</td><td rowspan=1 colspan=1>0.951</td><td rowspan=1 colspan=1>0.968</td></tr><tr><td rowspan=1 colspan=1>Intercept (mmol/L)</td><td rowspan=1 colspan=1>1.80</td><td rowspan=1 colspan=1>-1.04</td><td rowspan=1 colspan=1>2.82</td></tr><tr><td rowspan=1 colspan=1>Systematic Error (mmol/L)ObservedAllowed</td><td rowspan=1 colspan=1>0.600.83</td><td rowspan=1 colspan=1>1.011.05</td><td rowspan=1 colspan=1>1.7%1.8%</td></tr><tr><td rowspan=1 colspan=1>Range (mmol/L)</td><td rowspan=1 colspan=1>13.00 - 349.70</td><td rowspan=1 colspan=1>2.40 - 187.87</td><td rowspan=1 colspan=1>39.07 - 402.97</td></tr></table>

c. Traceability, Stability, Expected values (controls, calibrators, or methods):

The cleared calibrators used for the performance studies were as follows: Chemistry Methods JAS Chemistry Calibrator   
JAS Diagnostics, Inc.   
k020454   
ISE Methods - Calibrant A and Calibrant B   
Medica Corporation   
k000926

d. Detection limit:

The photometric assays were evaluated using EP17-A: Protocols for Determination of Limits of Detection and Limits of Quantitation; Approved Guideline.

<table><tr><td rowspan=1 colspan=4>LOB/LOD/LOQ Data - Clinical Chemistry</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Glucose Hexokinase</td><td rowspan=1 colspan=1>Creatinine</td><td rowspan=1 colspan=1>Urea Nitrogen (BUN)</td></tr><tr><td rowspan=1 colspan=1>LOB(mg/dL)</td><td rowspan=1 colspan=1>8.31</td><td rowspan=1 colspan=1>0.11</td><td rowspan=1 colspan=1>3.71</td></tr><tr><td rowspan=1 colspan=1>LOD(mg/dL)</td><td rowspan=1 colspan=1>12.0</td><td rowspan=1 colspan=1>0.17</td><td rowspan=1 colspan=1>4.7</td></tr><tr><td rowspan=1 colspan=1>LOQ(mg/dL)% CV</td><td rowspan=1 colspan=1>16.613.66</td><td rowspan=1 colspan=1>0.2316.88</td><td rowspan=1 colspan=1>5.511.47</td></tr></table>

Not Applicable for ISE methods

# e. Analytical specificity:

Interference studies were performed following the CLSI standard, EP7-A: Interference Testing in Clinical Chemistry; Approved Guideline. The procedure used to evaluate interference was to assay a series of samples with known concentrations of interferent. Percent recoveries were calculated for each sample with interferent versus the matched sample without interferent. Interference was defined as the level at which less than a $10 \%$ difference was observed between a sample with and without interferent. Interferent concentrations above those stated in Table 3 would contribute to invalid patient results.

<table><tr><td rowspan=1 colspan=4>Interference - Clinical Chemistry</td></tr><tr><td rowspan=1 colspan=1>Interferent</td><td rowspan=1 colspan=1>Glucose Hexokinase</td><td rowspan=1 colspan=1>Creatinine</td><td rowspan=1 colspan=1>Urea Nitrogen (BUN)</td></tr><tr><td rowspan=1 colspan=1>Hemoglobin (mg/dL)</td><td rowspan=1 colspan=1>200</td><td rowspan=1 colspan=1>No interference up to 1000</td><td rowspan=1 colspan=1>1000</td></tr><tr><td rowspan=1 colspan=1>Bilirubin (mg/dL)</td><td rowspan=1 colspan=1>23.4</td><td rowspan=1 colspan=1>6.7</td><td rowspan=1 colspan=1>No interference up to 39.3</td></tr><tr><td rowspan=1 colspan=1>Triglycerides (mg/dL)</td><td rowspan=1 colspan=1>370</td><td rowspan=1 colspan=1>1117.5</td><td rowspan=1 colspan=1>No interference up to 994</td></tr></table>

The below table reports the concentration of interferent where interference was not observed with a specific ISE serum method assayed by the TRILOGY Analyzer.

<table><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Interfering substance: Bilirubin</td></tr><tr><td colspan="1" rowspan="1">Analyte concentration</td><td colspan="1" rowspan="1">EY</td></tr><tr><td colspan="1" rowspan="1">Sodium</td><td colspan="1" rowspan="1">EY</td></tr><tr><td colspan="1" rowspan="1">162 mmol/l</td><td colspan="1" rowspan="1">35.3 mg/dl</td></tr><tr><td colspan="1" rowspan="1">189 mmol/1</td><td colspan="1" rowspan="1">20.2 mg/dl</td></tr><tr><td colspan="1" rowspan="1">Potassium</td><td colspan="1" rowspan="1">EY</td></tr><tr><td colspan="1" rowspan="1">4.41 mmol/l</td><td colspan="1" rowspan="1">41.4 mg/dl</td></tr><tr><td colspan="1" rowspan="1">8.26 mmol/1</td><td colspan="1" rowspan="1">21.7 mg/dl</td></tr><tr><td colspan="1" rowspan="1">Chloride</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">107 mmol/1</td><td colspan="1" rowspan="1">41.3 mg/dl</td></tr><tr><td colspan="1" rowspan="1">130 mmol/1</td><td colspan="1" rowspan="1">21.1 mg/dl</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Interfering substance: Hemoglobin</td></tr><tr><td colspan="1" rowspan="1">Sodium</td><td colspan="1" rowspan="1">EY</td></tr><tr><td colspan="1" rowspan="1">140 mmol/1</td><td colspan="1" rowspan="1">679 mg/dl</td></tr><tr><td colspan="1" rowspan="1">149 mmol/1</td><td colspan="1" rowspan="1">871 mg/dl</td></tr><tr><td colspan="1" rowspan="1">Potassium</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Do not use hemolyzed samples</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Do not use hemolyzed samples</td></tr><tr><td colspan="1" rowspan="1">Chloride</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">100 mmol/1</td><td colspan="1" rowspan="1">921 mg/dl</td></tr><tr><td colspan="1" rowspan="1">113 mmol/1</td><td colspan="1" rowspan="1">1000 mg/dl</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Interfering substance: Triglycerides</td></tr><tr><td colspan="1" rowspan="1">Sodium</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">140 mmol/1</td><td colspan="1" rowspan="1">2296 mg/dl</td></tr><tr><td colspan="1" rowspan="1">148 mmol/1</td><td colspan="1" rowspan="1">2038 mg/dl</td></tr><tr><td colspan="1" rowspan="1">Potassium</td><td colspan="1" rowspan="1">EY</td></tr><tr><td colspan="1" rowspan="1">4.20 mmol/1</td><td colspan="1" rowspan="1">2296 mg/dl</td></tr><tr><td colspan="1" rowspan="1">6.85 mmol/1</td><td colspan="1" rowspan="1">2366 mg/dl</td></tr><tr><td colspan="1" rowspan="1">Chloride</td><td colspan="1" rowspan="1">EY</td></tr><tr><td colspan="1" rowspan="1">99.5 mmol/l</td><td colspan="1" rowspan="1">2296 mg/dl</td></tr><tr><td colspan="1" rowspan="1">110.4 mmol/l</td><td colspan="1" rowspan="1">2366 mg/dl</td></tr></table>

f. Assay cut-off: Not applicable

2. Comparison studies:

a. Method comparison with predicate device: Clinical Chemistry Methods

Serum specimens were assayed using the TRILOGY Analyzer and Roche COBAS MIRA® for each clinical chemistry method. Regression statistics were calculated as follows:

Method Comparison Studies – Clinical Chemistry Methods   

<table><tr><td rowspan=1 colspan=4>Method Comparison  Clinical Chemistry</td></tr><tr><td rowspan=1 colspan=1>Key Statistics</td><td rowspan=1 colspan=1>GlucoseHexokinase</td><td rowspan=1 colspan=1>Creatinine</td><td rowspan=1 colspan=1>Urea Nitrogen(BUN)</td></tr><tr><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>62</td><td rowspan=1 colspan=1>69</td><td rowspan=1 colspan=1>70</td></tr><tr><td rowspan=1 colspan=1>Corr. Coeff. (R)</td><td rowspan=1 colspan=1>0.9946</td><td rowspan=1 colspan=1>0.9945</td><td rowspan=1 colspan=1>0.9956</td></tr><tr><td rowspan=1 colspan=1>Slope*(95% CI)</td><td rowspan=1 colspan=1>0.9902(0.9643 - 1.016)</td><td rowspan=1 colspan=1>0.9860(0.9614- 1.011)</td><td rowspan=1 colspan=1>1.088(1.064 - 1.112)</td></tr><tr><td rowspan=1 colspan=1>Intercept* (mg/dL)(95% CI)</td><td rowspan=1 colspan=1>7.0(2.8 - 11.2)</td><td rowspan=1 colspan=1>0.03(-0.11 - 0.16)</td><td rowspan=1 colspan=1>-2.43(-3.30 - -1.55)</td></tr><tr><td rowspan=1 colspan=1>Range (mg/dL)</td><td rowspan=1 colspan=1>42.0 - 463.0</td><td rowspan=1 colspan=1>0.7 - 14.7</td><td rowspan=1 colspan=1>4.8- 80.0</td></tr></table>

$^ * =$ Data presented are Deming linear regression statistics

# ISE Serum Methods

Serum specimens were assayed using the TRILOGY Analyzer with ISE module and Medica EasyElectrolytes for each ISE serum method. Regression statistics were calculated as follows:

Method Comparison Studies – ISE Serum Methods   

<table><tr><td rowspan=1 colspan=4>Method Comparison - ISE Serum</td></tr><tr><td rowspan=1 colspan=1>Key Statistics</td><td rowspan=1 colspan=1>Sodium</td><td rowspan=1 colspan=1>Potassium</td><td rowspan=1 colspan=1>Chloride</td></tr><tr><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>101</td><td rowspan=1 colspan=1>101</td><td rowspan=1 colspan=1>94</td></tr><tr><td rowspan=1 colspan=1>Corr. Coeff. (R)</td><td rowspan=1 colspan=1>0.9869</td><td rowspan=1 colspan=1>0.9979</td><td rowspan=1 colspan=1>0.9972</td></tr><tr><td rowspan=1 colspan=1>Slope*(95% CI)</td><td rowspan=1 colspan=1>0.972(0.941 - 1.004)</td><td rowspan=1 colspan=1>1.004(0.991 - 1.017)</td><td rowspan=1 colspan=1>0.854(0.840  0.867)</td></tr><tr><td rowspan=1 colspan=1>Intercept*(mmol/L)(95% CI)</td><td rowspan=1 colspan=1>6.2(1.8 - 10.6)</td><td rowspan=1 colspan=1>0.11(0.05 - 0.17)</td><td rowspan=1 colspan=1>14.8(13.5 - 16.2)</td></tr><tr><td rowspan=1 colspan=1>Range (mmol/L)</td><td rowspan=1 colspan=1>107.0 - 183.0</td><td rowspan=1 colspan=1>2.1 - 9.6</td><td rowspan=1 colspan=1>56.0 - 149.0</td></tr></table>

$^ { * } =$ Data presented are Deming linear regression statistics

# ISE Urine Methods

Urine specimens were assayed using the TRILOGY Analyzer with ISE module and Medica EasyElectrolytes for each ISE urine method. Regression statistics were calculated as follows:

Method Comparison Studies – ISE Urine Methods   

<table><tr><td rowspan=1 colspan=4>Method Comparison - ISE Urine</td></tr><tr><td rowspan=1 colspan=1>Key Statistics</td><td rowspan=1 colspan=1>Sodium</td><td rowspan=1 colspan=1>Potassium</td><td rowspan=1 colspan=1>Chloride</td></tr><tr><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>76</td><td rowspan=1 colspan=1>77</td><td rowspan=1 colspan=1>76</td></tr><tr><td rowspan=1 colspan=1>Corr. Coeff. (R)</td><td rowspan=1 colspan=1>0.9972</td><td rowspan=1 colspan=1>0.9969</td><td rowspan=1 colspan=1>0.9967</td></tr><tr><td rowspan=1 colspan=1>Slope*(95% CI)</td><td rowspan=1 colspan=1>0.989(0.971 - 1.006)</td><td rowspan=1 colspan=1>1.020(1.002  1.039)</td><td rowspan=1 colspan=1>1.046(1.026  1.065)</td></tr><tr><td rowspan=1 colspan=1>Intercept* (mmol/L)(95% CI)</td><td rowspan=1 colspan=1>0.69(-2.33  3.71)</td><td rowspan=1 colspan=1>-0.521(-1.789 - 0.747)</td><td rowspan=1 colspan=1>-3.36(-7.12 - 0.39)</td></tr><tr><td rowspan=1 colspan=1>Range (mmol/L)</td><td rowspan=1 colspan=1>14.3 - 291.9</td><td rowspan=1 colspan=1>11.27 - 145.6</td><td rowspan=1 colspan=1>40.3 - 353.2</td></tr></table>

$^ * =$ Data presented are Deming linear regression statistics

$b$ . Matrix comparison: See ISE urine method comparison above

3. Clinical studies:

a. Clinical Sensitivity: Not Applicable

$b$ . Clinical specificity: Not Applicable

c. Other clinical supportive data (when a. and b. are not applicable): Not Applicable

4. Clinical cut-off: Not Applicable

5. Expected values/Reference range: See k011900, k003247, k011596, and k000926

N. Instrument Name: TRILOGY Analyzer

# O. System Descriptions:

1. Modes of Operation: Random access routine and stat modes

2. Software:

FDA has reviewed applicant’s Hazard Analysis and software development processes for this line of product types:

Yes ___X____ or No

3. Specimen Identification: Barcode

4. Specimen Sampling and Handling: Sample tube carousel

5. Calibration:

End-point, enzymatic and quadratic curve-fitting can be chosen to analyze data. Calibration curve-fitting parameters such as Linear (linear regression, bilogarithmic regression, weighted linear) and Non-linear (Logit-Log, Exponential and Polynomial) are available.

6. Quality Control:

The operational software of the TRILOGY Analyzer contains a database, which is capable of storing results from previous analyses. The operator can view raw data and graphs for each clinical chemistry and ISE method. QC options also allow displays for evaluating data using Westgard Rules, viewing Levey-Jennings plots, reviewing statistical performance and exporting the QC data in Text File (TXT)

format.

# P. Other Supportive Instrument Performance Characteristics Data Not Covered In The “Performance Characteristics” Section above:

None

Q. Proposed Labeling: The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.

# R. Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.